Using automated text messages to monitor adverse events following immunisation in general practice

Medical Journal of Australia

Volumn 200, Issue 7, 2014, Pages 416-418

  Leeb, Alan ^a   Regan, Annette K ^b   Peters, Ian J ^a   Leeb, Candice ^a   Leeb, Gregory ^c   Effler, Paul V ^b,d  

^a Illawarra Medical Centre ^*  (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c BOND UNIVERSITY   (Australia)

^d DEPARTMENT OF HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHILD; CLUSTER ANALYSIS; ELECTRONIC MEDICAL RECORD; FEMALE; GENERAL PRACTICE; HUMAN; IMMUNIZATION; INFANT; INFORMATION SERVICE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MIDDLE AGED; PERFORMANCE; PRESCHOOL CHILD; SCHOOL CHILD; SEASONAL INFLUENZA; SMARTVAX; TELECONSULTATION; TEXT MESSAGING; VACCINATION; YOUNG ADULT; ATTITUDE TO HEALTH; AUSTRALIA; HEALTH SURVEY; MASS IMMUNIZATION; METHODOLOGY; STATISTICS; TELEMEDICINE; UTILIZATION REVIEW;

INFLUENZA VACCINE;

ADULT; AUSTRALIA; CHILD; FEMALE; GENERAL PRACTICE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFLUENZA VACCINES; MALE; MASS VACCINATION; POPULATION SURVEILLANCE; TELEMEDICINE; TEXT MESSAGING;

EID: 84902490809     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.11166     Document Type: Article

References (9)

1. Armstrong PK, Dowse GK, Effler PV, et al. Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine. BMJ Open 2011; 1: e000016.
2. Horvath J. Review of the management of adverse events associated with Panvax and Fluvax: final report 10 March 2011. Canberra: Australian Government Department of Health and Ageing, 2011. http://www.health.gov.au/internet/ immunise/publishing.nsf/Content/11DFBB4 FD968D072CA25789400172DA1/$File/adverseevent-march-2011.pdf (accessed Oct 2013).
3. Gold MS, Effler P, Kelly H, et al. Febrile convulsions after 2010 seasonal trivalent influenza vaccine: implications for vaccine safety surveillance in Australia [editorial]. Med J Aust 2010; 193: 492-493.
4. Mahajan D, Roomiani I, Gold MS, et al. Annual report: surveillance of adverse events following immunisation in Australia, 2009. Commun Dis Intell Q Rep 2010; 34: 259-276.
5. Zhou W, Pool V, Iskander JK, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. MMWR Surveill Summ 2003; 52: 1-24.
6. Rosenthal S, Chen R. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health 1995; 85: 1706-1709.
7. Baron S, Goutard F, Nguon K, Tarantola A. Use of a text message-based pharmacovigilance tool in Cambodia: pilot study. J Med Internet Res 2013; 15: e68.
8. Kaplan WA. Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? Global Health 2006; 2: 9.
9. Best Practice Software. Media statement. 15 Apr 2013. MIMS Matters 2013; Winter Edition: 7. http://www.mims.com.au/content/MimsMatters/ WinterMMJul13.pdf (accessed Mar 2014).